Interview with John C W Lim, CEO, Health Sciences Authority
HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite…
C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the product fields of Vascular, Urology, Oncology and Surgical Specialty.
BARD markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.
BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.
Contact:
Bard Singapore Pte. Ltd.
1 Harbourfront Avenue
#04-11/13, Keppel Bay Tower
Singapore 098632
Phone: +65-6580-5988
Website: https://www.crbard.sg
HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite…
In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore and describe its main…
Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more consumers, particularly in emerging…
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
The merger with Invitrogen-Applied Biosystems in 2008 was a big milestone for the company. As one of the leaders of this integration, can you please explain how this merger helped…
In the past two years Life Technologies has been investing in Singapore— last year you opened a regional distribution center in Singapore’s Tuas Biomedical Park and this June you established…
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for…
What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the discovery and development of…
What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical division (prescription and OTC…
Can you please give our readers a brief introduction of AB SCIEX? AB SCIEX provides scientific solutions for its customers, who are scientists that are dealing with complex chemistry, drug…
See our Cookie Privacy Policy Here
